Serum adipokine profiles in Kawasaki disease

Modern Rheumatology

Volumn 22, Issue 1, 2012, Pages 66-72

  Kemmotsu, Yasushi ^a   Saji, Tsutomu ^a   Kusunoki, Natsuko ^a   Tanaka, Nahoko ^a   Nishimura, Chiaki ^b   Ishiguro, Akira ^c   Kawai, Shinichi ^a  

^a TOHO UNIVERSITY   (Japan)

^b TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

Adipokines; C reactive protein; Kawasaki disease; Resistin

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; IMMUNOGLOBULIN; LEPTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; RESISTIN;

ADULT; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION;

ADIPOKINES; ADIPONECTIN; C-REACTIVE PROTEIN; CHILD, PRESCHOOL; COMMUNICABLE DISEASES; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; LEPTIN; MALE; MOLECULAR WEIGHT; MUCOCUTANEOUS LYMPH NODE SYNDROME; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; RESISTIN;

EID: 84861018686     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-011-0468-x     Document Type: Article

References (32)

1. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi. 1967;16:178-222.
2. Dajani AS, Taubert KA, Gerber MA, et al. Diagnosis and therapy of Kawasaki disease in children. Circulation. 1993;87:1776-80. (Pubitemid 23133135)
3. Nakamura Y, Yashiro M, Uehara R, Oki I, Watanabe M, Yanagawa H. Epidemiologic features of Kawasaki disease in Japan: results from the Nationwide Survey in 2005-2006. J Epidemiol. 2008;18:167-72.
4. Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol. 2010;316:129-39.
5. Dyck DJ, Heigenhauser GJ, Bruce CR. The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity. Acta Physiol (Oxf). 2006;186:5-16.
6. Rasouli N, Kern PA. Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab. 2008;93(11 Suppl 1):S64-73.
7. Steppan CM, Brown EJ, Wright CM, et al. A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci USA. 2001;98:502-6. (Pubitemid 32105071)
8. Degawa-Yamaguchi M, Bovenkerk JE, Juliar BE, et al. Serum resistin (FIZZ3) protein is increased in obese humans. J Clin Endocrinol Metab. 2003;88:5452-5. (Pubitemid 37452753)
9. Muredach PR, Michael L, Megan LW, Anand R, Mitcell AL, Daniel JR. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation. 2005;111:932-9.
10. Kobayashi H, Ouchi N, Kihara S, et al. Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res. 2004;94:e27-31.
11. Pajvani UB, Hawkins M, Combs TP, et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione- mediated improvement in insulin sensitivity. J Biol Chem. 2004;279:12152-62. (Pubitemid 38445780)
12. Shinha MK, Caro JF. Clinical aspects of leptin. Vitam Horm. 1998;54:1-30.
13. Havel PJ, Kasim-Karakas S, Mueller W, et al. Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: effects of dietary fat content and sustained weight loss. J Clin Endocrinol Metab. 1996;81: 4406-13. (Pubitemid 26412052)
14. Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science. 2005;307:426-30. (Pubitemid 40139988)
15. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol. 2006;6: 772-83. (Pubitemid 44453463)
16. Yoshino T, Kusunoki N, Tanaka N, et al. Elevated serum levels of resistin, leptin, and adiponectin are associated with C-reactive protein and also other clinical conditions in rheumatoid arthritis. Intern Med. 2011;50:269-75.
17. Nozue H, Imai H, Saitoh H, Aoki T, Ichikawa K, Kamoda T. Serum resistin concentrations in children with Kawasaki disease. Inflamm Res. 2010;59:915-20.
18. Yang RZ, Huang Q, Xu A, et al. Comparative studies of resistin expression and phylogenomics in human and mouse. Biochem Biophys Res Commun. 2003;310:927-35. (Pubitemid 37188711)
19. Patel L, Buckels AC, Kinghorn IJ, et al. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun. 2003;300:472-6. (Pubitemid 38375833)
20. Fujiwara H, Hamashima Y. Pathology of the heart in Kawasaki disease. Pediatrics. 1978;61:100-7. (Pubitemid 8268802)
21. Ichiyama T, Yoshitomi T, Nishikawa M, et al. NF-kappaB activation in peripheral blood monocytes/macrophages and T cells during acute Kawasaki disease. Clin Immunol. 2001;99:373-7.
22. Tarkowski A, Bjersing J, Shestakov A, Bokarewa MI. Resistin competes with lipopolysaccharide for binding to toll-like receptor 4. J Cell Mol Med. 2010;14(6B):1419-31.
23. Wang GB, Li CR, Zu Y, Yuan XW. The role of activation of toll-like receptors in immunological pathogenesis of Kawasaki disease. Zhonghua Er Ke Za Zhi. 2006;44:333-336 (in Chinese).
24. Egami K, Muta H, Ishii M, Suda K, Sugahara Y, Iemura M, Matsuishi T. Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr. 2006;149:237-40. (Pubitemid 44128552)
25. Kobayashi T, Inoue Y, Takeuchi K, Okada Y, Tamura K, Tomomasa T, Kobayashi T, Morikawa A. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation. 2006;113:2606-12. (Pubitemid 43948009)
26. Watanabe T, Abe Y, Sato S, Uehara Y, Ikeno K, Abe T. Hyponatremia in Kawasaki disease. Pediatr Nephrol. 2006;21: 778-81. (Pubitemid 43740943)
27. Takeshita S, Takabayashi H, Yoshida N. Circulating adiponectin levels in Kawasaki disease. Acta Paediatr. 2006;95:1312-4. (Pubitemid 44423203)
28. Senzaki H. The pathophysiology of coronary artery aneurysms in Kawasaki disease: role of matrix metalloproteinases. Arch Dis Child. 2006;91:847-51. (Pubitemid 44521172)
29. Kitahara K, Kusunoki N, Kakiuchi T, Suguro T, Kawai S. Adiponectin stimulates IL-8 production by rheumatoid synovial fibroblasts. Biochem Biophys Res Commun. 2009;378:218-23.
30. Kusunoki N, Kitahara K, Kojima F, et al. Adiponectin stimulates prostaglandin E2 production in rheumatoid synovial fibroblasts. Arthritis Rheum. 2010;62:1641-9.
31. Ehling A, Schaffler A, Herfarth H, Tarner IH, Anders S, Distler O, et al. The potential of adiponectin in driving arthritis. J Immunol. 2006;176:4468-78. (Pubitemid 44264427)
32. Ozgen M, Koca SS, Aksoy K, Dagli N, Ustundag B, Isik A. Visfatin levels and intima-media thicknesses in rheumatic diseases. Clin Rheumatol. 2010 (Epub ahead of print).